FindMyRecallSubscribe
Class I: serious health riskOngoing

Wisconsin Pharmacal MG217 Multi-Symptom Treatment Cream & Skin Recall

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%)

Wisconsin Pharmacal Company · Jackson, WI

Risk level
Class I
Reported by FDA
May 27, 2026
Recall ID
D-0553-2026
Check your lot numberHow we source this data

Summary

Wisconsin Pharmacal recalled MG217 Multi-Symptom Treatment Cream & Skin starting Apr 24, 2026. The FDA classified it as Class I (serious health risk) and published enforcement report D-0553-2026 on May 27, 2026. Reason: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus. Status: Ongoing.

Why it was recalled

Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.

Product description

MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.

Lot numbers, UPCs & expiration codes

Lot #: 1024088, Exp 11/30/2026

Where it was sold

USA Nationwide and Bahamas

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0553-2026
Classification
Class I
Status
Ongoing
Recall initiated
Apr 24, 2026
FDA report date
May 27, 2026
Quantity
690 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Wisconsin Pharmacal Company

Original FDA data

Every field from FDA enforcement report D-0553-2026, exactly as published.

Show all FDA fields
City
Jackson
State
WI
Status
Ongoing
Country
United States
Event ID
98788
Address
N168w22223 Main St
Code information
Lot #: 1024088, Exp 11/30/2026
Postal code
53037
Report date
May 27, 2026
Product type
Drugs
Recall number
D-0553-2026
Classification
Class I
Recalling firm
Wisconsin Pharmacal Company
Product quantity
690 tubes
Reason for recall
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Voluntary / mandated
Voluntary: Firm initiated
Product description
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Distribution pattern
USA Nationwide and Bahamas
Recall initiation date
Apr 24, 2026
Initial firm notification
Letter
Center classification date
May 29, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0553-2026, published May 27, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls